Trial Profile
A Randomized Open Label Clinical Trial of Fixed Dose Letrozole vs. Titrated Letrozole for In Vitro Fertilization With Cryopreservation of Oocytes and Embryos in Breast Cancer Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2022
Price :
$35
*
At a glance
- Drugs Letrozole (Primary)
- Indications Breast cancer; Female infertility
- Focus Therapeutic Use
- 18 Nov 2022 Status changed from active, no longer recruiting to completed.
- 20 Nov 2021 Planned End Date changed from 30 Sep 2021 to 30 Sep 2022.
- 29 Jul 2021 Planned End Date changed from 30 May 2021 to 30 Sep 2021.